<- Go home

Added to YB: 2016-02-23

Pitch date: 2016-02-23

HBIO:US [bullish]

Harvard Bioscience, Inc.

-77.55%

current return

Author Info

No bio for this author

Company Info

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States, Germany, and internationally.

Market Cap

$29.4M

Pitch Price

$3.30

Price Target

N/A

Dividend

N/A

EV/EBITDA

8.98

P/E

-0.54

EV/Sales

0.75

Sector

Life Sciences Tools and Services

Category

N/A

Show full summary:
Harvard Bioscience Inc HBIO:US

A summary for this pitch has not been created yet.

Read full article (0 min)